FDMT
#2786
4D Molecular Therapeutics, Inc. - Common Stock
11.7 0 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.54%
Monthly Change
+27.31%
6 month change
+51.95%
Year Change
+3.54%
Previous Close
11.3 0
Open
11.7 0
Low
11.7 0
High
11.7 0
Volume
72
Financials
- Market Capitalization 611.63 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.1
Price to sales ratio
5.1
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2778 |  NGNE Neurogene Inc. - Common Stock | 39.08 USD | +1.98% | +6.37% | +30.27% | +32.83% | 617.54 M USD | ||
| 2782 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.34 USD | 0.00% | -7.17% | +8.93% | -23.24% | 615.16 M USD | ||
| 2800 |  FBRX Forte Biosciences, Inc. - Common Stock | 43.20 USD | -2.09% | +96.45% | +139.34% | +47.19% | 599.86 M USD | ||
| 2823 |  IMMX Immix Biopharma, Inc. - Common Stock | 10.68 USD | +1.52% | -8.87% | +25.65% | +278.72% | 581.11 M USD |
Frequently asked questions about 4D Molecular Therapeutics, Inc. - Common Stock
What is the 4D Molecular Therapeutics, Inc. - Common Stock stock price today?
The current price of 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) is 11.7. Over the past 24 hours, the stock has changed by +3.54%. Follow the FDMT chart for real-time price dynamics.
What is the stock ticker of 4D Molecular Therapeutics, Inc. - Common Stock?
4D Molecular Therapeutics, Inc. - Common Stock trades under the ticker FDMT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 4D Molecular Therapeutics, Inc. - Common Stock stock going up?
FDMT has changed by -4.88% over the last week, +27.31% over the last month, and +3.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was 4D Molecular Therapeutics, Inc. - Common Stock net income for the last quarter?
4D Molecular Therapeutics, Inc. - Common Stock reported net income of -68.76 M for the last quarter. The previous quarter showed 19.4 M, which means net income changed by -454.49%.
How many employees does 4D Molecular Therapeutics, Inc. - Common Stock have?
As of the latest available data, 4D Molecular Therapeutics, Inc. - Common Stock has 196 employees. Workforce size can provide additional context about the company's scale and operations.
What is 4D Molecular Therapeutics, Inc. - Common Stock EBITDA?
4D Molecular Therapeutics, Inc. - Common Stock EBITDA is -73.45 M, and its EBITDA margin is -2 410.7%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 4D Molecular Therapeutics, Inc. - Common Stock stock?
You can buy 4D Molecular Therapeutics, Inc. - Common Stock (FDMT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 4D Molecular Therapeutics, Inc. - Common Stock stock?
Investing in 4D Molecular Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FDMT chart and related analysis on metatrader.com as part of your research.